SYNCRIP and acute lymphoblastic leukemia: In human T-ALL cells, ribosome and mitochondrial dysfunction were observed along with deletion of the SYNCRIP-SNHG5 region, which developed leukemia more efficiently in the competitive engraftment experiment and limit-dilution experiment, indicating increased malignancy and enhanced leukemia-initiating cell (LIC) activity.